comprehensive -WSS

comprehensive

author：entertainment 2025-08-25 05:57:03 - browse：78222

New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company. Jonathan Wiggs/Globe staff

CAMBRIDGE, Mass. — When drug giant Sanofi restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger “specialty care” portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.

Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold. He’s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi’s $20.1 billion takeover offer in 2011.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： 1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

explore

WSS

Israel withdraws forces after 2

After sickle

In diabetes hearing, Sanders takes on a new foe: food makers

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Radiology is caught between AI's potential and concern for patients

Americans' trust in science, scientist continues decline: Report

hotspot

comprehensive

entertainment

Activists slam private health insurers over coverage restrictions

China dismisses criticism of top diplomat's comments appearing to push for race

Walensky prepares to leave CDC — and Congress — behind

Pfizer plans to depart BIO

DIEP, the 'gold standard' of breast reconstruction, is under threat

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

At least 13 dead in Texas as scorching temps continue

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Guidelines to prevent youth baseball injuries need more muscle

Israel withdraws forces after 2

Wikipedia

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

EU moves toward latest gene techniques in food production to counter climate change, shortages

Chemotherapy shortages won’t get better under Biden’s latest plan

Former New York Mayor de Blasio and wife announce separation, but not divorce

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

explore

explore

hotspot

knowledge